REFERENCIAS.

1. Ball A.M, Sole M. Oxidative Stress and The Pathogenesis of Heart Failure. Cardiology Clinic 1998; 4: 665-675.

2. Colucci W. Molecular and Cellular Mechanisms of myocardial failure, Am J. Cardiol 1997;80(11A): 15L-25L.

3. Stringer MD, Gorog PC, Freeman A, et als, Lipid peroxides and Atherosclerosis. BMJ.1989;298:281-284.

4. Bridges AB, McNeill GP, Pringle TH, et als. A late increase in free radical activity post myocardial infarction. Eur Heart J. 1995; 16:899-902.

5. Bolli R. Mechanisms of myocardial "Stunning" Circulation. 1990;82:723-738.

6. Rice-Evans C,Bruckdorfer KR. Free Radicals , Lipoproteins and Cardiovascular disfunction. Mol Aspects Med 1992;13:1-111

7. Naranjan S, Dhalla, Rana M. Temas And Thomas Netticadan Role Of oxidative stress in Cardiovascular Diseases. J Hypertens 2000,18:655-673.

8. White CR, Brock TA, Chang LY et als; Superoxide and Perynitrite in Atherosclerosis. Proc Natl Acad Sci USA 1994;91: 1044-1048.

9. Nakasono K, Watanabe N, Matsuno K, et al. Does Superoxide underlie the patogénesis of Hipertensión? Proc Natl Acad Sci USA 1991;88:10045-10048.

10. Wang X, Takeda S, Mochizuki S, Jindal R, Dhalla NS, Mechanisms of hydrogen peroxide-induced increase intracellular calcium in cardiomyocytes J. Cardiovasc Pharmacol Therapeut 1999;4:41-48.

11. Moncada S, Higgs A. The L-Arginine-Nitric oxide pathway. N.Engl J. Med 1993; 329:2002-2012.

12. Laurindo FR, daLuz PL, Uint L, Rocha TF et als Evidence for superoxide radical-dependent coronary vasospasm after angio`plasty in intact dogs . Circulation 1991;83:1705-1715.

13. Lockitch G, Selenium: Clinical Significance and analytical concepts. Crit Rev Clin Lab Sci 1989; 27:483-541.

14. Signal PK, Khaper N, Palace V, Kumar D, The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998;40:426-432.

15. Singal PK, Kapur N, Dhillon KS; Beamish RE, Dhalla NS; Role of free radicals in Cathecholamine-induced cardiomyopathy Can J. Physiol Pharmacol 1982;60:1390-1397.

16. Singal PK, Yates JC, Beamish RE, Dhalla NS, Influence of reducing agents on adenocrome-induced changes in the heart . Arch Pathol Lab Med 1981;105:664-669.

17. Wohaieb SA, Godin DV, Alterations in free radicals tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987;36:1014-1018.

18. Doroshow JH, Effect of anthracycline antibiotic on oxygen radical formation in rat heart Cancer Res 1983;43:460-472.

19. Singal PK, lliskovic N, Doxorubicin-induced cardiomyopathy N Eng. J Med 1998;339: 900-905.

20. Kumar D, Kirshenbaum L, Danelisen I, Singal P. Apoptosis in isolated adult cardiomyocytes exposed to adriamicin Ann NY Acad Sci 1999;874;156-168.

21. Silveski-Lliscovic N, Hill M, Chow DA, Singal PK. Probucol Protects against adriamycin cardiomiopathy without interfering with its antitumor effect. Circulation. 1995;91:10-15.

22. Kirshenbaum La, Singal PK, Antioxidant changes in heart hypertrophy: Significance during hypoxia-reoxygenation injury . Can J Physiol Pharmacol 1992; 70: 1330-1335.

23. Gupta M, Singal PK, Higher antioxidative capacity during a Chronic stable heart hypertrophy Circ Res 1989;64:398-406.

24. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure J. am Coll Cardiol 1996;28:506-514.

25. Yusuf S, Dagenais G, Pogue J, Bosch J Sleight P Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 2000; 342:154-160.

26. Hill MF, Singal PK, Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats Am J Pathol 1996;148-291-300.

27. Diaz-Velez CR, Garcia-castineirasS, Mendoza-Ramos. Hernández Lopez E, Increased Malondialdehyde in peripheral blood of patients with congestive Herat failure Am Heart J. 1996;131:146-152.

28. Ghatac A, Brar MJ, Agarwal A et al, Oxyfree radical system in heart failure and therapeutic role of oral vitamin E Int J Cardiol 1996;57:119-127.

29. Ruffolo RR, Feuerstein GZ, Ohlstein EH. Recent observations with beta adrenoceptor blockade. Beneficial effects in hypertension and heart failure. Am J Hypertens 1998; 11:9S-14S.